Search
                    Washington, DC Paid Clinical Trials
A listing of 816  clinical trials  in Washington, DC  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            493 - 504 of 816
        
                There are currently 816 clinical trials in Washington, District Of Columbia looking for participants to engage in research studies. Trials are conducted at various facilities, including Children's National Medical Center, Medstar Georgetown University Hospital, MedStar Washington Hospital Center and Walter Reed Army Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you. 
            
                                        Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    Featured Trial
                
                Cardiovascular Disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Cardiovascular Disease
    
    
                            Conditions: 
                                    
        
            
                        Cardiovascular Disease
                    
                                    Featured Trial
                
                Peripheral vascular disease Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Peripheral vascular disease
    
    
                            Conditions: 
                                    
        
            
                        Peripheral vascular disease
                    
                                    
                
                                    Evaluating Novel Therapies in ctDNA Positive GI Cancers
                                
            
            
        Recruiting
                            
            
                This study is a non-randomized, open-label, multi-cohort, multi-site, pilot feasibility therapeutic trial. The study will enroll 20 patients across 4 cohorts (CRC, gastric, PDAC, and HCC/intra-hepatic-/extra-hepatic-, gall bladder adenocarcinomas) diagnosed with histologically confirmed GI cancers. These patients will have already completed all Standard of Care (SOC) treatments (including neoadjuvant, surgery, local therapies, and/or adjuvant therapy as applicable), as defined by the treating pr...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/20/2025
            
            Locations: Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia  +1 locations         
        
        
            Conditions: Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma, Pancreatic Adenocarcinoma, Hepatocellular Carcinoma, Adenocarcinoma of Biliary Tract, Gallbladder Adenocarcinoma
        
            
        
    
                
                                    Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
                                
            
            
        Recruiting
                            
            
                This phase III trial compares the effect of sentinel lymph node mapping to standard lymph node dissection in reducing the risk of swelling in the legs (lymphedema) in patients undergoing a hysterectomy for stage I endometrial cancer. Standard lymph node dissection removes lymph nodes around the uterus during a hysterectomy to look for spread of cancer from the uterus to nearby lymph nodes. Sentinel lymph node mapping uses a special dye and camera to look for cancer that may have spread to nearby...  Read More             
        
        
    Gender:
                FEMALE
            Ages:
                18 years and above
            Trial Updated:
                05/20/2025
            
            Locations: George Washington University Medical Center, Washington, District of Columbia         
        
        
            Conditions: Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
        
            
        
    
                
                                    Daratumumab for Polyneuropathy Associated With MGUS
                                
            
            
        Recruiting
                            
            
                The goal of this clinical trial is to learn about daratumumab and hyaluronidase-fihj in patients with monoclonal gammopathy of undetermined significant (MGUS) who have been diagnosed with peripheral neuropathy suspected to be cause by paraproteinemia. The main question\[s\] it aims to answer are:
• how well does this medication help improve MGUS associated peripheral neuropathy
Participants will be asked be asked to get some testing done prior to starting the trial in order for us to assess yo...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/20/2025
            
            Locations: Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia         
        
        
            Conditions: Peripheral Neuropathy, Monoclonal Gammopathy of Undetermined Significance
        
            
        
    
                
                                    Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
                                
            
            
        Recruiting
                            
            
                To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/19/2025
            
            Locations: Medstar Washington Hospital Center, Washington, District of Columbia         
        
        
            Conditions: Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
        
            
        
    
                
                                    Immunization With BCG Vaccine to Prevent Tuberculosis Infection
                                
            
            
        Recruiting
                            
            
                The purpose of this research is to find out if a single dose of pre-travel vaccination with BCG can lessen tuberculosis (TB) infection by producing an immune response when given to adults traveling to countries with a high burden of TB. BCG will be compared with a placebo (an inactive vaccine). BCG (Japan) is used globally but is not approved for use in the United States, therefore it is considered experimental. Participants choosing to take part in this research study, will be randomly assigned...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 65 years
            Trial Updated:
                05/19/2025
            
            Locations: MedStar Washington Hospital Center/MedStar Health Research Institute, Washington, District of Columbia         
        
        
            Conditions: Tuberculosis Infection
        
            
        
    
                
                                    Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
                                
            
            
        Recruiting
                            
            
                The goal of this study is to assess the incidence of the composite of thrombotic events (TEs) and thromboembolic events (TEEs) in patients with congenital antithrombin deficiency under when they receive Atenativ for surgical procedures or parturition.             
        
        
    Gender:
                ALL
            Ages:
                Between 12 years and 80 years
            Trial Updated:
                05/19/2025
            
            Locations: Georgetown University, Washington, District of Columbia         
        
        
            Conditions: Congenital Antithrombin Deficiency
        
            
        
    
                
                                    ZILRETTA in Subjects With Shoulder Osteoarthritis
                                
            
            
        Recruiting
                            
            
                Primary Objective: To assess the efficacy of ZILRETTA on pain following an intra-articular (IA) injection in subjects with glenohumeral osteoarthritis (OA) relative to normal saline placebo
Secondary Objective:
* To assess the efficacy of ZILRETTA on pain following an IA injection in subjects with glenohumeral OA relative to triamcinolone acetonide injectable suspension, immediate release (TCA-IR) and normal saline placebo
* To assess the safety of ZILRETTA in subjects with glenohumeral OA rel...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 50 years and 80 years
            Trial Updated:
                05/19/2025
            
            Locations: International Spine, Pain & Performance Center, Washington, District of Columbia         
        
        
            Conditions: Glenohumeral Osteoarthritis
        
            
        
    
                
                                    Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
                                
            
            
        Recruiting
                            
            
                This is a multi-institution, open label, phase I/II study of Iberdomide, Carfilzomib, and dexamethasone (KID) in patients with newly diagnosed transplant eligible MM.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/16/2025
            
            Locations: Lombardi Comprehensive Cancer Center, Washington, District of Columbia         
        
        
            Conditions: Multiple Myeloma
        
            
        
    
                
                                    Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use
                                
            
            
        Recruiting
                            
            
                This is a two-group randomized controlled trial conducted at five hospitals across the U.S. designed to test the effectiveness of an Integrated infectious diseases/Substance Use Disorder outpatient clinic (IC) compared to treatment as usual aimed at reducing infection related readmissions and improving health outcomes in people hospitalized with an infection related to injecting opioids or stimulants.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/16/2025
            
            Locations: George Washington University, Washington, District of Columbia         
        
        
            Conditions: Opioid Use Disorder, Injection Related Infections, Stimulant Use Disorder
        
            
        
    
                
                                    VIBRating vs Traditional Therapy for Treatment of ENTry Dyspareunia
                                
            
            
        Recruiting
                            
            
                The goal of this randomized controlled trial is to determine whether the use of a novel vibrating pelvic floor therapeutic device ("Kiwi") improves sexual function in sexually active women aged 18 and older with genito-pelvic pain and penetration disorder (GPPPD) more effectively than traditional vaginal dilators.
The main questions it aims to answer are:
1. Does the use of the Kiwi device lead to higher sexual function scores compared to traditional vaginal dilators
2. Does the Kiwi device im...  Read More             
        
        
    Gender:
                FEMALE
            Ages:
                18 years and above
            Trial Updated:
                05/16/2025
            
            Locations: MedStar Health, Washington, District of Columbia         
        
        
            Conditions: Genito-Pelvic Pain/Penetration Disorder, Dyspareunia, Vaginismus, Pelvic Pain, Vestibulodynia, Vulvodynia (chronic Vulvar Pain)
        
            
        
    
                
                                    A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
                                
            
            
        Recruiting
                            
            
                This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study may help doctors determine if the two surgical procedures are nearly the same for ovarian cancer risk...  Read More             
        
        
    Gender:
                FEMALE
            Ages:
                Between 35 years and 50 years
            Trial Updated:
                05/15/2025
            
            Locations: George Washington University Medical Center, Washington, District of Columbia         
        
        
            Conditions: Ovarian Carcinoma
        
            
        
    
                
                                    Late Onset Alzheimer's Disease
                                
            
            
        Recruiting
                            
            
                The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.             
        
        
    Gender:
                ALL
            Ages:
                55 years and above
            Trial Updated:
                05/15/2025
            
            Locations: University of Washington, Washington, District of Columbia         
        
        
            Conditions: Alzheimer Disease
        
            
        
    493 - 504 of 816
            